WASHINGTON, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)MELANOMA RESEARCH FOUNDATION, founded in 1996, is a community nonprofit in the Unknown sector that reported $7.8M in total revenue in fiscal year 2023. Revenue grew 18% year-over-year, indicating healthy expansion. Expenses of $6.7M left a modest 14% surplus.
THE MRF IS THE LARGEST INDEPENDENT ORGANIZATION DEVOTED TO MELANOMA. ITS MISSION IS TO ERADICATE MELANOMA BY ACCELERATING MEDICAL RESEARCH WHILE EDUCATING TO AND ADVOCATING FOR THE MELANOMA COMMUNITY.
THE MRF IS COMMITTED TO ADVANCING A BROAD SCIENTIFIC AGENDA ACROSS THE DISCIPLINES OF PREVENTION, DIAGNOSIS, AND TREATMENT. ALTHOUGH THE MRF HAS ACHIEVED A NUMBER OF IMPORTANT SCIENTIFIC MILESTONES...
THE MRF IS COMMITTED TO ADVANCING A BROAD SCIENTIFIC AGENDA ACROSS THE DISCIPLINES OF PREVENTION, DIAGNOSIS, AND TREATMENT. ALTHOUGH THE MRF HAS ACHIEVED A NUMBER OF IMPORTANT SCIENTIFIC MILESTONES, MUCH MORE WORK REMAINS TO BE DONE. TO THIS END, THE MRF FUNDS A SPECTRUM OF RESEARCH GRANTS, SCIENTIFIC INITIATIVES, AND PROGRAMS FOR CUTANEOUS MELANOMA AND RARER MELANOMA SUBTYPES (E.G. OCULAR, PEDIATRIC, ACRAL AND MUCOSAL MELANOMA). ITS RESEARCH GRANT PROGRAM IS A COMPETITIVE, PEER-REVIEWED RESEARCH GRANT PROGRAM FOR INVESTIGATOR-INITIATED RESEARCH HAS BEEN IN EXISTENCE SINCE 1998. MRF-SUPPORTED RESEARCH IS OPEN TO MEDICAL STUDENTS THROUGH SENIOR INVESTIGATIVE TEAMS AND ENCOMPASS.
THE MRF'S ADVOCACY PROGRAM IS A PLATFORM FOR THOSE AFFECTED BY MELANOMA TO SHARE THEIR VOICE AND TRANSFORM MELANOMA CARE. PATIENTS, CAREGIVERS, SURVIVORS, HEALTHCARE PROFESSIONALS AND PARTNERS ALL...
THE MRF'S ADVOCACY PROGRAM IS A PLATFORM FOR THOSE AFFECTED BY MELANOMA TO SHARE THEIR VOICE AND TRANSFORM MELANOMA CARE. PATIENTS, CAREGIVERS, SURVIVORS, HEALTHCARE PROFESSIONALS AND PARTNERS ALL PLAY A CRITICAL ROLE IN THE ADVANCEMENT OF BETTER OUTCOMES FOR THE OVER ONE MILLION AMERICANS LIVING WITH MELANOMA AND THEIR LOVED ONES.
THE MRF HAS A ROBUST EDUCATION PROGRAM AIMED AT EDUCATING PATIENTS AND PHYSICIANS ABOUT THE PREVENTION, DIAGNOSIS, AND TREATMENT OF MELANOMA, AS WELL AS INCREASING OVERALL AWARENESS OF THE DISEASE...
THE MRF HAS A ROBUST EDUCATION PROGRAM AIMED AT EDUCATING PATIENTS AND PHYSICIANS ABOUT THE PREVENTION, DIAGNOSIS, AND TREATMENT OF MELANOMA, AS WELL AS INCREASING OVERALL AWARENESS OF THE DISEASE. IN ADDITION, THE MRF MAINTAINS A LARGE PORTFOLIO OF FREE EDUCATIONAL MATERIALS THAT CAN BE USED AT FUNDRAISERS, DOCTORS' OFFICES, SCHOOLS, AND HEALTH FAIRS.PART OF THE MRF'S EDUCATIONAL OFFERINGS ALSO INCLUDE PATIENT-FOCUSED EDUCATIONAL SYMPOSIA THROUGHOUT THE U.S., IMPACTING NEARLY 1,500 PEOPLE TOUCHED BY MELANOMA. THESE SYMPOSIA PROVIDE MELANOMA PATIENTS AND THE PEOPLE WHO SUPPORT THEM THE OPPORTUNITY TO LEARN FROM LEADING MELANOMA EXPERTS ON THE MOST CURRENT PREVENTION, DIAGNOSIS, TREATMENT, AND RESEARCH INFORMATION.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $7,774,562 | $6,578,223 | +0.2% |
| Expenses | $6,697,219 | $6,478,760 | +0.0% |
| Net Income | $1,077,343 | $99,463 | +9.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| KYLEIGH LIPIRA | CEO | 40.00 |
Officer
Director
|
$336,485 | $11,196 | $347,681 |
| JAMES MERRICK | CHIEF COMMUNICATIONS OFFICER | 40.00 |
Highest
|
$178,462 | $8,755 | $187,217 |
| JESSICA ALLISON | DIRECTOR OF CORPORATE RELATIONS | 40.00 |
Highest
|
$114,686 | $10,907 | $125,593 |
| DOUGLAS BRODMAN | CHAIR | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| ALISON MARTIN MD | VICE CHAIR - UNTIL 01/2024 | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| THOMAS WESTDYK SECRETARY | AND GOVERNANCE - AS OF 01/2024 | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| CHERUL STRATOS | SECRETARY - UNTIL 12/2023 | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| JILL WROBEL | TREASURER | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| STAN ADLER | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL B ATKINS MD | SAC CO-CHAIR | 1.00 |
Director
|
$0 | $0 | $0 |
| ELISE BARISH | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| KRISTINA BAUM | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| LAURA FERRIS MD | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| GLENN MERLINO | SAC CO-CHAIR - UNTIL 12/2023 | 1.00 |
Director
|
$0 | $0 | $0 |
| GIULIA NEWTON | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| ASHANI WEERARATNA MD | SAC CO-CHAIR | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $7,774,562 | $6,697,219 | $7,270,872 | $1,077,343 |
| 2023 | $6,578,223 | $6,478,760 | $6,173,374 | $99,463 |
| 2022 | $6,918,058 | $5,575,310 | $5,064,088 | $1,342,748 |
| 2021 | $5,128,245 | $4,808,451 | $4,048,990 | $319,794 |
| 2020 | $5,640,236 | $5,203,544 | $2,657,969 | $436,692 |
| 2019 | $5,352,231 | $4,807,267 | $1,963,873 | $544,964 |
Compare MELANOMA RESEARCH FOUNDATION with other nonprofits in District of Columbia and across the country.